1st Quarter - Report

AETNA INC. for AETNA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,641,400
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 19, 2010 $1,641,400 Replaced
1st Quarter - Amendment Nov 4, 2011 $1,641,400 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Department of Defense Appropriations

LobbyistCovered position, as disclosed
JOHN SILVIO CLASS —
JONATHAN TOPODAS —

Contacted: SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Capital Loss Carrybacks

LobbyistCovered position, as disclosed
CHARLYN IOVINO —

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB)

Retirement RET

HR 1332, Emergency Retiree Health Benefits Protection Act of 2009 (Retiree health insuraance)

LobbyistCovered position, as disclosed
CHARLYN IOVINO —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1332 (111th)

Medicare/Medicaid MMM

HR 1 ARRA (increase in FMAP and moratorium on Medicaid Regulations). HR 2 SCHIP, HR 904/S 547 (Medicaid drug rebates). HR 684/S 330 (establish Government PDPs). S 266 (government run negotiation of drug prices in Medicare.) S 75 (to promote generic drugs in Medicare). S 677 (means-test Part B premiums). S 1832 (to regulate Part D plan prices). S 960 (Medicare Buy-In for age 55-64). HR 3961 ("Doc Fix"). S. 2128 (MM Fraud & Abuse) S 1776 (SGR).

LobbyistCovered position, as disclosed
STEVEN B KELMAR —
MOLLY SCHILD —
JONATHAN TOPODAS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 3961 (111th), H.R. 1 (111th), H.R. 684 (111th), H.R. 2 (111th), S. 2128 (111th), H.R. 904 (111th)

Insurance INS

HR 1583 (McCarran-Ferguson). S 819 (Autism). HR 1253 (disclosure rules) HR 1691/S 688 (prohibit plan rescissions and establish minimum hospital stays for cancer patients) HR 1558/S623 ; also HR 1619, S. 643, HR 1092 (prohibit pre-existing condition exclusions). S. 442/ HR 1085 (prohibit aggregate lifetime limit) S. 697 /HR 1721 (Long Term Care) HR 975 (Mammography mandate) HR 1339 (Mandate to fcover deformities)

LobbyistCovered position, as disclosed
CHARLYN IOVINO —
STEVEN B KELMAR —
CHRISTINA NYQUIST —
JONATHAN TOPODAS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: H.R. 1253 (111th), H.R. 1619 (111th), H.R. 1085 (111th), H.R. 1583 (111th), H.R. 1339 (111th), H.R. 1092 (111th), S. 697 (111th), S. 643 (111th), H.R. 975 (111th), H.R. 1558 (111th), H.R. 1691 (111th), H.R. 1721 (111th), S. 442 (111th)

Torts TOR

HR 1086 (Medical Malpractice liability reform)

LobbyistCovered position, as disclosed
STEVEN B KELMAR —
JONATHAN TOPODAS —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1086 (111th)

Health Issues HCR

S 1796, S 1679, HR 3962, HR 3590 (Health Care Reform). HR 1204 (Antitrust exemption for pharmacists) HR 1493 (Antitrust exemption for physicians) HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT). HR 1427/S 726/ HR 1548 (FDA PAthway to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (Generic/brand settlements). S. 93 (establish FEHBP for small employers) S 391/HR 1321 (National health) HR 676/S. 703 (single payer); PL 111-148; PL 111-152.

LobbyistCovered position, as disclosed
CHARLYN IOVINO —
STEVEN B KELMAR —
CHRISTINA NYQUIST —
MOLLY SCHILD —
JONATHAN TOPODAS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: S. 93 (111th), H.R. 1706 (111th), H.R. 1548 (111th), H.R. 3590 (111th), H.R. 1493 (111th), H.R. 676 (111th), H.R. 1427 (111th), H.R. 3962 (111th), H.R. 1321 (111th), S. 369 (111th), S. 703 (111th), H.R. 1204 (111th), H.R. 1 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.